# LIB Therapeutics LLC

Organization · id `cardio:org-lib-therapeutics-llc` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=LIB+Therapeutics+LLC>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 5 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: LIB Therapeutics LLC
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: Trial to Evaluate Efficacy and Safety of LIB003, Evolocumab and Alirocumab in High-risk CVD Patients (`cardio:ct-nct04790513`)
- Sponsors: Long-term Efficacy and Safety of OLE LIB003 in HoFH, HeFH, and High-risk CVD Patients Requiring Further LDL-C Reduction (`cardio:ct-nct04798430`)
- Sponsors: Study of Long-Term Efficacy and Safety of LIB003 in CVD or High Risk for CVD Patients Needing Further LDL-C Reduction (`cardio:ct-nct04806893`)
- Sponsors: Trial to Evaluate Efficacy and Safety of LIB003 and Inclisiran in High-risk CVD Patients (`cardio:ct-nct05004675`)
- Sponsors: Study to Evaluate the Efficacy and Safety of Lerodalcibep in Children 6 to 17 Years, With Heterozygous FH (`cardio:ct-nct07102511`)

## Provenance

Content hash: e1a8de99a22ad5d4e4130747563c596a103a218e9f9e8f49818d523083980e96
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
